NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $141.55 -0.04 (-0.03%) (As of 11/29/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends About iShares Biotechnology ETF (NASDAQ:IBB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get IBB alerts:Sign Up Key Stats Today's Range$140.98▼$142.1750-Day Range$133.04▼$148.8552-Week Range$119.95▼$150.57Volume1.59 million shsAverage Volume1.46 million shsMarket Capitalization$6.99 billionAssets Under Management$6.90 billionDividend Yield0.32%Net Expense Ratio0.45%Aggregate RatingModerate Buy ETF OverviewiShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More… Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.45%0.57%0.55%0.50%0.52%Other Expenses0.00%0.30%0.49%0.40%0.53%Total Expense0.45%0.70%0.71%0.63%0.71%Fee Waiver0.00%-0.45%-0.52%-0.32%-0.57%Net Expense0.45%0.61%0.61%0.56%0.59% Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBB ETF News HeadlinesIs Biotech’s Bull Run Over? Examining Election ImpactsThe biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup.November 21, 2024 | marketbeat.comIs Biotech's Bull Run Over? Examining Election ImpactsNovember 21, 2024 | msn.comCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.December 1, 2024 | Brownstone Research (Ad)Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is WatchingNovember 8, 2024 | msn.comIs the ARKK Fund Ready to Play Nice?October 29, 2024 | investing.comBiotech Stocks About to Make a Seasonal Move Higher? Here's How to Spot a BreakoutOctober 22, 2024 | investing.comSee More Headlines IBB ETF - Frequently Asked Questions How have IBB shares performed this year? iShares Biotechnology ETF's stock was trading at $135.85 at the beginning of the year. Since then, IBB shares have increased by 4.2% and is now trading at $141.55. View the best growth stocks for 2024 here. When did iShares Biotechnology ETF's stock split? Shares of iShares Biotechnology ETF split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. Who are iShares Biotechnology ETF's major shareholders? Top institutional shareholders of iShares Biotechnology ETF include BNP Paribas Financial Markets (4.75%), Commerce Bank (1.47%), Healthcare of Ontario Pension Plan Trust Fund (1.32%) and Main Management ETF Advisors LLC (1.18%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC). Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings218 Fund Statistics Assets Under Management$6.90 billion Average Daily Volume$1.54 million Discount/Premium-0.07% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume618 Put Options338 Call Options280 Short Interest10,280,000 shs Miscellaneous Outstanding Shares49,350,000Beta0.84 Creation Unit50,000 Creation Fee$614.00 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Top 10 IBB HoldingsGilead Sciences (NASDAQ:GILD)Holding Weight: 9.62%Vertex Pharmaceuticals (NASDAQ:VRTX)Holding Weight: 8.19%Amgen (NASDAQ:AMGN)Holding Weight: 7.41%Regeneron Pharmaceuticals (NASDAQ:REGN)Holding Weight: 5.57%IQVIA (NYSE:IQV)Holding Weight: 3.73%Alnylam Pharmaceuticals (NASDAQ:ALNY)Holding Weight: 3.28%argenx (NASDAQ:ARGX)Holding Weight: 2.97%Mettler-Toledo International (NYSE:MTD)Holding Weight: 2.58%Biogen (NASDAQ:BIIB)Holding Weight: 2.34%Illumina (NASDAQ:ILMN)Holding Weight: 2.26%Full Holdings DetailsIBB Sector ExposureIBB Industry Exposure This page (NASDAQ:IBB) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts